UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics

Clinical and experimental allergy, 2014-08, Vol.44 (8), p.1044-1052

2014

Volltextzugriff (PDF)

Glutathione‐PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first‐in‐human study

British journal of clinical pharmacology, 2018-05, Vol.84 (5), p.1020-1028

2018

Volltextzugriff (PDF)

The use of machine learning improves the assessment of drug-induced driving behaviour

Accident analysis and prevention, 2020-12, Vol.148, p.105822-105822, Article 105822

2020

Volltextzugriff (PDF)

Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers

Journal of psychopharmacology (Oxford), 2023-06, Vol.37 (6), p.577-589

2023

Volltextzugriff (PDF)

The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men

Clinical therapeutics, 2011-10, Vol.33 (10), p.1492-1502

2011

Volltextzugriff (PDF)

Using machine learning techniques to characterize sleep-deprived driving behavior

Traffic injury prevention, 2021, Vol.22 (5), p.366-371

2021

Volltextzugriff (PDF)

341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration

Sleep (New York, N.Y.), 2021-05, Vol.44 (Supplement_2), p.A136-A136

2021

Volltextzugriff (PDF)

Positioning functional foods in an ecological approach to the prevention of overweight and obesity

Obesity reviews, 2008-09, Vol.9 (5), p.464-473

2008

Volltextzugriff (PDF)

On the use of the Goodman diagram for high cycle fatigue design

International journal of fracture, 1996-04, Vol.80 (2-3), p.219-235

1996

Volltextzugriff (PDF)

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Journal of psychopharmacology (Oxford), 2019-02, Vol.33 (2), p.202-209

2019

Volltextzugriff (PDF)

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

The lancet respiratory medicine, 2013-11, Vol.1 (9), p.714-727

2013

Volltextzugriff (PDF)

0008 Night-Time Administration Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Pharmacokinetics, Next-Day Residual Effects, Safety, And Tolerability

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A3-A3

2018

Volltextzugriff (PDF)

0007 Multiple-Ascending-Dose Study Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, And Tolerability

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A3-A3

2018

Volltextzugriff (PDF)

P.2.f.035 - JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

European neuropsychopharmacology, 2017-10, Vol.27, p.S866-S866

2017

Volltextzugriff (PDF)

JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

European neuropsychopharmacology, 2017-10, Vol.27, p.S866

2017

Volltextzugriff (PDF)

The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

European neuropsychopharmacology, 2017-10, Vol.27, p.S655-S656

2017

Volltextzugriff (PDF)

P.1.g.029 - The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

European neuropsychopharmacology, 2017-10, Vol.27, p.S655-S656

2017

Volltextzugriff (PDF)

Setipiprant, a selective CRTH 2 antagonist, reduces allergen‐induced airway responses in allergic asthmatics

Clinical and experimental allergy, 2014-08, Vol.44 (8), p.1044-1052

2014

Volltextzugriff (PDF)

Functionally graded materials: Choice of micromechanics model and limitations in property variation

Composites engineering, 1995, Vol.5 (7), p.807-819

Zuiker, Joseph R.

1995

Volltextzugriff (PDF)

On the use of the Goodman diagram for high cycle fatigue design : High cycle fatigue

International journal of fracture, 1996, Vol.80 (2-3), p.219-235

1996

Volltextzugriff (PDF)

Appendix I - Computation of High Cycle Fatigue Design Limits under Combined High and Low Cycle Fatigue

High Cycle Fatigue, 2006, p.617-638

Zuiker, Joseph R.

2006

Volltextzugriff (PDF)

Simultaneous measurement of intra-epidermal electric detection thresholds and evoked potentials for observation of nociceptive processing following sleep deprivation

Experimental brain research, 2022-02, Vol.240 (2), p.631-649

2022

Volltextzugriff (PDF)

Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations

British journal of clinical pharmacology, 2022-05, Vol.88 (5), p.2236-2245

2022

Volltextzugriff (PDF)

NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects

Journal of psychopharmacology (Oxford), 2016-03, Vol.30 (3), p.253-262

2016

Volltextzugriff (PDF)

Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol

Journal of psychopharmacology (Oxford), 2019-07, Vol.33 (7), p.791-800

2019

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaPhysics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics

Glutathione‐PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first‐in‐human study

The use of machine learning improves the assessment of drug-induced driving behaviour

Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers

The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men

Using machine learning techniques to characterize sleep-deprived driving behavior

341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration

Positioning functional foods in an ecological approach to the prevention of overweight and obesity

On the use of the Goodman diagram for high cycle fatigue design

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

0008 Night-Time Administration Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Pharmacokinetics, Next-Day Residual Effects, Safety, And Tolerability

0007 Multiple-Ascending-Dose Study Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, And Tolerability

P.2.f.035 - JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

P.1.g.029 - The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

Setipiprant, a selective CRTH 2 antagonist, reduces allergen‐induced airway responses in allergic asthmatics

Functionally graded materials: Choice of micromechanics model and limitations in property variation

On the use of the Goodman diagram for high cycle fatigue design : High cycle fatigue

Appendix I - Computation of High Cycle Fatigue Design Limits under Combined High and Low Cycle Fatigue

Simultaneous measurement of intra-epidermal electric detection thresholds and evoked potentials for observation of nociceptive processing following sleep deprivation

Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations

NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects

Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol

Aktive Filter

Suchergebnisse filtern